News
Form 8.3 - Maitland Institutional Services Limited: Form 8.3 - Clinigen Group plc
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Poxel Announces the Formation of its Scientific Advisory Board for Rare Metabolic Diseases
POXEL SA (Euronext – POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic diseases with metabolic pathophysiology, including non-alcoholic
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that on December 1, 2021, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc: Opening Position Disclosure
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to five new employees.
On December 1
Role of B Cells Induced by IMV’s Lead Compound in Patients with Ovarian Cancer to be Showcased at the ESMO-IO Congress
IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX™ platform to treat solid and blood cancers, today announced
Deciphera Pharmaceuticals Announces Restructuring to Prioritize Clinical Development Programs and Streamline Commercial Operations
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today announced a corporate
IMV Announces First Patient Dosed in Phase 1b Clinical Study Evaluating its Lead Compound in Patients with Breast Cancer
IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and blood cancers while preserving
DGAP-News: Biotest AG: Biotest receives approval for Intratect(R) in France
DGAP-News: Biotest AG: Biotest erhält die Zulassung für Intratect(R) in Frankreich
DGAP-News: Biotest AG: Biotest AG eröffnet 7. Plasmasammelzentrum in Tschechien
DGAP-News: Biotest AG: Biotest AG opens seventh plasma collection centre in Czech Republic
DGAP-News: Biotest AG: Biotest beschleunigt die Entwicklung von Trimodulin bei hospitalisierten COVID-19-Patienten mit Bundesmitteln in Höhe von 29 Millionen Euro
DGAP-News: Biotest AG: Biotest accelerates trimodulin development in hospitalized COVID-19 patients with federal funding in the volume of 29 million EUR
EnWave unterzeichnet kostenpflichtige kommerzielle Lizenzvereinbarung und Ausrüstungskaufvertrag mit Nippon Trends Food Services, Inc.
Vancouver, B.C., 1. Dezember 2020. Die EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave", oder das "Unternehmen" - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/ ) gab
EnWave Signs Royalty-Bearing Commercial License Agreement and Equipment Purchase Agreement with Nippon Trends Food Services, Inc.
Vancouver, B.C., December 1, 2020. EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company” - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/ ) announced
EnWave Signs Second Equipment Purchase Agreement with Patata Torres to Increase REV™ Manufacturing Capacity by 100kW
Vancouver, B.C., November 30, 2020
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company” - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/) announced
EnWave unterzeichnet zweiten Anlagenkaufvertrag mit Patata Torres um die REV™ Fertigungskapazität um 100kW zu erhöhen
Vancouver, B.C., 30. November 2020
Die EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave", oder das "Unternehmen" - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/ ) gab
EnWave Signs Royalty-Bearing Commercial License and Receives Deposit for 70kW of REV™ Machinery from NuWave Foods for the Production of Shelf-Stable Baked Goods
Vancouver, B.C., November 23, 2020
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company” - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/) announced
EnWave unterzeichnet lizenzgebührenpflichtige kommerzielle Lizenz und erhält eine Anzahlung für 70kW REV™ Anlage von NuWave Foods für die Herstellung von haltbaren Backwaren
Vancouver, B.C., 23. November 2020
Die EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave", oder das "Unternehmen" - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/ ) gab
EnWave Appoints Mr. Pablo Cussatti to its Board of Directors, Announces Retirement of Director, Mr. Hugh McKinnon
Vancouver, B.C., November 20, 2020
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company" - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/), announced today
EnWave beruft Pablo Cussatti in den Verwaltungsrat und kündigt Rücktritt des Direktors Hugh McKinnon an
Vancouver, B.C., 20. November 2020
Die EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave", oder das "Unternehmen" - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/) gab
Der ACEMAGIC S1 Mini PC: Kompakte Power und Vielseitigkeit für Deinen digitalen Alltag – Jetzt zu einem unschlagbaren Preis!
